# Efficacy Study of Lisdexamfetamine to Treat Binge Eating Disorder

> **NCT01090713** · PHASE3 · COMPLETED · sponsor: **Lindner Center of HOPE** · enrollment: 50 (actual)

## Conditions studied

- Binge Eating Disorder

## Interventions

- **DRUG:** lisdexamfetamine
- **DRUG:** Placebo control

## Key facts

- **NCT ID:** NCT01090713
- **Lead sponsor:** Lindner Center of HOPE
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2016-07-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01090713

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01090713, "Efficacy Study of Lisdexamfetamine to Treat Binge Eating Disorder". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01090713. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*